Literature DB >> 16619539

A related donor and reduced intensity conditioning reduces the risk of development of BK virus-positive haemorrhagic cystitis in allogeneic haematopoetic stem cell-transplanted patients.

Gordana Bogdanovic1, Peter Priftakis, Geraldine Giraud, Tina Dalianis.   

Abstract

The significance of the BK virus (BKV) and possible co-factors for the development of late onset haemorrhagic cystitis (HC) in allogeneic haematopoetic stem cell (HSCT)-transplanted patients is reviewed. BKV-associated HC causes significant morbidity and mortality in HSCT patients, however, BK-viruria cannot distinguish patients at risk of HC, since it is observed in patients with and without HC. Several studies have therefore attempted to identify co-factors for the development of HC. Acute graft versus host disease was in the past, though less so recently, reported to correlate to the incidence of HC. However, patients who had received grafts from unrelated donors (URD) and had had full conditioning prior to HSCT were shown to have an increased risk of HC, compared to patients who had received HSCT from a related donor (RD) or patients who had received reduced intensity conditioning. In conclusion, HSCT patients with BK-viruria, an URD and receiving full conditioning have an increased risk of developing HC.

Entities:  

Mesh:

Year:  2006        PMID: 16619539

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  L Gilis; S Morisset; G Billaud; S Ducastelle-Leprêtre; H Labussière-Wallet; F-E Nicolini; F Barraco; M Detrait; X Thomas; N Tedone; M Sobh; C Chidiac; T Ferry; G Salles; M Michallet; F Ader
Journal:  Bone Marrow Transplant       Date:  2014-02-03       Impact factor: 5.483

2.  Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type.

Authors:  Leandro de Padua Silva; Poliana A Patah; Rima M Saliba; Nicholas A Szewczyk; Lisa Gilman; Joyce Neumann; Xiang-Yang Han; Jeffrey Tarrand; Rachel Ribeiro; Alison Gulbis; Elizabeth J Shpall; Roy Jones; Uday Popat; Julia A Walker; Demetrios Petropoulos; Alexandre Chiattone; John Stewart; Maha El-Zimaity; Paolo Anderlini; Sergio Giralt; Richard E Champlin; Marcos de Lima
Journal:  Haematologica       Date:  2010-04-21       Impact factor: 9.941

3.  Identification of a third human polyomavirus.

Authors:  Tobias Allander; Kalle Andreasson; Shawon Gupta; Annelie Bjerkner; Gordana Bogdanovic; Mats A A Persson; Tina Dalianis; Torbjörn Ramqvist; Björn Andersson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

4.  Development and evaluation of real-time PCR assays for the detection of the newly identified KI and WU polyomaviruses.

Authors:  S Bialasiewicz; D M Whiley; S B Lambert; A Gould; M D Nissen; T P Sloots
Journal:  J Clin Virol       Date:  2007-08-21       Impact factor: 3.168

5.  Risk factors associated with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

Authors:  Biao Shen; Yueshen Ma; Haixiao Zhang; Mingyang Wang; Jia Liu; Jiaxin Cao; Wenwen Guo; Dan Feng; Donglin Yang; Rongli Zhang; Xin Chen; Qiaoling Ma; Weihua Zhai; Sizhou Feng; Mingzhe Han; Aiming Pang; Erlie Jiang
Journal:  Blood Sci       Date:  2022-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.